JWLABS technologies, know-how, feasability

JWLABS Products for 2007

     Not to mislead you, the 1995 Model B-27 Version 3 was the most successful Rife instrument in history, and virtually all of them are still in use even today. It was exactly what the public wanted, and it performed better than anything that had come before. In fact, only the new Model A is it's equal.

     On the drawing board is the new Model B-44ti programmable. We will also look at prototyping the super-secret Model F-4c, now 5 years in the making, provided we have the funds. Also on the drawing board is the SP-5d rechargeable. We have yet to perform feasibility studies on these new designs, and of course, most new designs do not necessarily work out. We conceive of them, design them, and sometimes, if we are excited enough about them, actually prototype them for testing. But these new technologies, like all new ideas, have a very high attrition rate, and for the most part, never make it to the production stage. Only Model A has made it that far. The present Model A has gone through 31 embodiments, and dozens of prototypes, to actually make it to the point where it can be sold for experimentation after 18 years of development. There were 53 embodiments of Model B after the B-27 came out. Only the B-38 and the B-44 had any promise.

     Consider that in 1991, we produced the first Model A3. It was a third the size of the present Model A and had about one fifth the power. It sold for $300. It was a great innovation in Rife technology, but there was no market for it. Of the few people who knew anything about Rife technology in the early '90's, nobody thought that a device that small, and that inexpensive, could ever be worthwhile. Ten years later, however, Hulda Clark sold thousands of little zappers, not even 5 percent as effective as our old Model A3.

     Markets change. People learn. Costs for some things go up, and for others costs go down. The Clark-Zapper failed utterly, but it helped condition the public for the new Model A, which gains market share almost daily.

JWLABS is presently working on developing much more advanced designs that can better accommodate the increasing proliferation of frequency resistant pathogenic strains and the apparent rapid recovery of some viruses after being devitalized. The spread of mycosis and Lymes disease, without any theory to explain it, have reached epidemic proportions.